Posted: 27 Jun 2013 02:00 PM PDT
Thursday, June 27, 2013
Wednesday, June 26, 2013
Posted: 26 Jun 2013 02:00 PM PDT
Results
of a Phase III clinical trial showed that a simple drug regimen of two
anti-clotting drugs - clopidogrel and aspirin - lowered the risk of
stroke by almost one-third, compared to the standard therapy of aspirin
alone, when given to patients who had minor or transient stroke symptoms
to prevent subsequent attacks.
Tuesday, June 18, 2013
Subscribe to:
Posts (Atom)